Bio & Pharma
Clinomics releases equipment that quickly finds lung cancer mutations
The device needs just 10 ml of whole blood to automatically conduct three key processes to achieve its goal
By Jul 21, 2023 (Gmt+09:00)
1
Min read
Most Read
Samsung steps up AR race with advanced microdisplay for smart glasses


When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven


Maybe Happy Ending: A robot love story that rewrote Broadway playbook


NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen


US auto parts tariffs take effect; Korea avoids heavy hit



The machine improves user convenience by automatically separating plasma and filtering out cell-free DNA when whole blood is added, it added.
The company’s One-Stop All-In-One System automatically separates blood components and nucleic acids from 10 ml of whole blood.
This equipment was jointly developed with Asan Medical Center in Seoul and the Cheonan, South Chungcheong Province-based Korea Institute of Industrial Technology. Clinical research done at Asan found sensitivity of 90% and specificity 85% compared to a biopsy.
In the second half of this year, Clinomics will submit a clinical trial protocol to the Ministry of Food and Drug Safety, with clinical trials planned at Asan.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
-
Corporate investmentLG Electronics breaks ground on $600 mn home appliance plant in India
16 HOURS AGO
-
-
E-commerceCoupang’s Q1 revenue up; quarterly dip signals rising competition
May 07, 2025 (Gmt+09:00)
-
Asset managementKorea Investment & Securities deepens global ties with 2nd IR in New York
May 07, 2025 (Gmt+09:00)
Comment 0
LOG IN